Clinical impact of serum transforming growth factor-alpha mRNA as a predictive biomarker for the prognosis of fulminant hepatitis.
Miura N, Kabashima H, Shimizu M, Sato R, Tsukamoto T, Harada T, Takahashi S, Endo R, Nakayama N, Takikawa Y, Mochida S, Suzuki K, Hasegawa J, Shiota G.
Miura N, et al. Among authors: nakayama n.
Hepatol Int. 2008 Jun;2(2):213-21. doi: 10.1007/s12072-008-9053-6. Epub 2008 Apr 9.
Hepatol Int. 2008.
PMID: 19669307
Free PMC article.